Clinical Trials on Secondary Hyperparathyroidism in United States
Total 755 results
-
National Center for Research Resources (NCRR)CompletedSecondary HyperparathyroidismUnited States
-
OPKO Health, Inc.CompletedSecondary Hyperparathyroidism | Vitamin D InsufficiencyUnited States
-
Deltanoid PharmaceuticalsCompletedSecondary HyperparathyroidismUnited States
-
University of Maryland, BaltimoreCompletedSecondary HyperparathyroidismUnited States
-
Kerstyn C. Zalesin, M.D.AbbottCompletedGastric Bypass | Parathyroid HormoneUnited States
-
KAI PharmaceuticalsCompletedSecondary HyperparathyroidismUnited States
-
Genzyme, a Sanofi CompanyCompletedSecondary HyperparathyroidismUnited States
-
Genzyme, a Sanofi CompanyCompletedSecondary HyperparathyroidismUnited States
-
AmgenCompletedSecondary Hyperparathyroidism in Patients With ESRD on HemodialysisUnited States
-
Montefiore Medical CenterTerminatedSecondary Hyperparathyroidism | HypercalcemiaUnited States
-
Roxane LaboratoriesCompletedHypocalcemia | Secondary HyperparathyroidismUnited States
-
AmgenCompletedChronic Kidney Disease, Secondary HyperparathyroidismBelgium, United States, Germany, Poland, United Kingdom, Lithuania
-
Genzyme, a Sanofi CompanyCompletedSecondary HyperparathyroidismUnited States
-
Weill Medical College of Cornell UniversityCompletedObesity | Vitamin D Deficiency | Secondary HyperparathyroidismUnited States
-
OPKO Health, Inc.CompletedVitamin D Insufficiency | CKD Stage 4 | CKD Stage 3 | Secondary Hyperparathyroidism Due to Renal CausesUnited States
-
KAI PharmaceuticalsCompletedHyperparathyroidism, SecondaryUnited States, Australia
-
Emory UniversityTerminatedHyperparathyroidism, SecondaryUnited States
-
AmgenCompletedSecondary Hyperparathyroidism, Chronic Kidney DiseaseUnited States, Czechia, Germany, France, Hungary, Greece, Belgium, Italy, Poland, Russian Federation, Ukraine
-
Atlanta VA Medical CenterEmory UniversityCompletedKidney DiseaseUnited States
-
AbbottCompletedChronic Kidney Disease | Secondary HyperparathyroidismUnited States
-
SanofiActive, not recruitingSecondary Hyperparathyroidism-Chronic Kidney DiseaseUnited States, Chile
-
AmgenTerminatedChronic Kidney Disease, Secondary HyperparathyroidismUnited States, Belgium, Italy, Hungary, Czechia, France, Germany, Greece, Spain, Poland, Russian Federation, Ukraine, New Zealand, Slovakia, Lithuania, Portugal
-
OPKO Health, Inc.CompletedChronic Kidney Disease | Secondary Hyperparathyroidism | Vitamin D InsufficiencyUnited States
-
AmgenRecruitingSecondary HyperparathyroidismSpain, Belgium, Germany, Czechia, Poland, France, Greece, Hungary, Italy, United Kingdom, Lithuania, Portugal
-
University of Colorado, DenverCompletedChronic Kidney Disease | Secondary HyperparathyroidismUnited States
-
Kenneth R. Phelps, M.D.Genzyme, a Sanofi CompanyCompletedHyperparathyroidism | Chronic Kidney DiseaseUnited States
-
Washington University School of MedicineAbbott; NorthShore University HealthSystem; Northwestern University Feinberg... and other collaboratorsCompletedChronic Kidney Disease | Secondary HyperparathyroidismUnited States
-
AmgenCompletedChronic Kidney Disease | Secondary Hyperparathyroidism | Hyperparathyroidism, SecondaryUnited States, Germany, United Kingdom
-
AbbottCompletedSecondary Hyperparathyroidism | Chronic Kidney Disease, Stage 5United States
-
University of VirginiaWithdrawnChronic Kidney Disease | Secondary HyperparathyroidismUnited States
-
AbbottCompletedEnd Stage Renal Disease | Secondary HyperparathyroidismUnited States
-
Salem Veterans Affairs Medical CenterAbbottCompletedChronic Kidney Disease | Secondary HyperparathyroidismUnited States
-
OPKO Health, Inc.Active, not recruitingChronic Kidney Diseases | Vitamin D Deficiency | Stage 5 Chronic Kidney Disease | Secondary Hyperparathyroidism Due to Renal CausesUnited States
-
Genzyme, a Sanofi CompanyCompletedRenal Failure | Secondary Hyperparathyroidism | Chronic Renal InsufficiencyUnited States, Puerto Rico
-
OPKO IP Holdings II, Inc.CompletedChronic Kidney Disease | Secondary Hyperparathyroidism | Chronic Renal Failure | Chronic Renal InsufficiencyUnited States
-
AbbVieRecruitingChronic Kidney Disease (CKD) | Secondary Hyperparathyroidism (SHPT)United States, Puerto Rico
-
AmgenCompletedSecondary HyperparathyroidismUnited States, Italy, Belgium, Switzerland, Hungary, Spain, Turkey, Poland, Portugal, United Kingdom, Czech Republic, Macedonia, The Former Yugoslav Republic of
-
OPKO IP Holdings II, Inc.CompletedChronic Kidney Disease | Secondary Hyperparathyroidism | Chronic Renal Failure | Chronic Renal InsufficiencyCanada, United States
-
AbbottCompletedHemodialysis | Chronic Kidney Disease | Secondary HyperparathyroidismUnited States, Czech Republic, Denmark, Germany, Greece, Italy, Netherlands, Portugal, Russian Federation, Spain, Sweden, United Kingdom
-
AmgenTerminatedHyperparathyroidism | Chronic Kidney Disease | Secondary Hyperparathyroidism | Hyperparathyroidism, Secondary | Kidney DiseaseUnited States, Belgium, Hungary, Spain, Australia, Germany, Poland, Mexico, Russian Federation, Slovakia
-
AmgenCompletedChronic Kidney Disease | Secondary HyperparathyroidismUnited States, Italy, Belgium, Denmark, Switzerland, Canada, Turkey, Spain, Austria, Germany, Hungary, Greece, France, Poland, Russian Federation, Czechia, Latvia, Lithuania, New Zealand, Portugal, Sweden, Estonia
-
University of California, Los AngelesLoma Linda UniversityCompletedSecondary HyperparathyroidismUnited States
-
OPKO IP Holdings II, Inc.CompletedChronic Kidney Disease | Secondary Hyperparathyroidism | Chronic Renal Failure | Chronic Renal InsufficiencyUnited States
-
Indiana University School of MedicineCompletedRenal OsteodystrophyUnited States
-
AmgenCompletedHyperparathyroidism, SecondaryUnited States
-
OPKO Health, Inc.RecruitingSecondary Hyperparathyroidism | Chronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Vitamin d DeficiencyUnited States
-
Thomas Nickolas, MD MSCompletedVascular Calcification | Chronic Kidney Disease Mineral and Bone Disorder | Hyperparathyroidism; Secondary, Renal | Renal OsteodystrophyUnited States
-
AmgenRecruitingChronic Kidney Disease | Secondary HyperparathyroidismKorea, Republic of, United States, India, Singapore, Taiwan, Argentina, Malaysia, Russian Federation, Turkey, Ukraine
-
OPKO IP Holdings II, Inc.CompletedVitamin D Deficiency | Chronic Kidney Disease | Hyperparathyroidism, SecondaryUnited States
-
AbbVie (prior sponsor, Abbott)North America Pediatric Renal Trials and Collaborative Studies (NAPRTCS)TerminatedEnd-Stage Renal Disease | Secondary HyperparathyroidismUnited States